INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ECOLE NORMALE SUPERIEURE DE LYON, UNIVERSITE CLAUDE BERNARD - LYON 1 FILES APPLICATION FOR "INHIBITOR OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILY (LDL-R FAMILY) AND/OR APOLIPOPROTEIN E (APOE) FOR USE IN THE TREATMENT OF CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS (CCHFV) INFECTION"

GENEVA, April 28 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3, Rue Michel Ange75016 Paris), ECOLE NORMALE SUPERIEURE DE LYON (15 Parvis Rene Descartes69007 Lyon), UNIVERSITE CLAUDE BERNARD - LYON 1 (43 Boulevard du 11 novembre 191869100 Villeurbanne) filed a patent application (PCT/EP2024/078978) for "INHIBITOR OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILY (LDL-R FAMILY) AND/OR APOLIPOPROTEIN E (APOE) FOR USE IN THE TREATMENT OF CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS (CCHFV) INFECTION" on Oct 15, 2024. With publication no. WO/2025/082944, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent applicati...